n-3 fatty acids and cardiovascular disease

Haematologica

Volumn 93, Issue 6, 2008, Pages 807-812

  Grundt, Heidi ^a,b   Nilsen, Dennis W T ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; DOCOSAHEXAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; INSULIN GLARGINE; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; ROSUVASTATIN; SUNFLOWER OIL;

ACUTE CORONARY SYNDROME; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG MEGADOSE; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HEART ARRHYTHMIA; HUMAN; LIPID PEROXIDATION; LOW DRUG DOSE; POLLUTANT; PRIMARY PREVENTION; PROTEIN FUNCTION; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; THROMBOGENICITY;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIET; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; INFLAMMATION; INUITS; MALE; MODELS, CHEMICAL; RISK FACTORS;

EID: 44949099233     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13191     Document Type: Editorial

References (29)

1. Hjermann I. The metabolic cardiovascular syndrome: syndrome X, Reaven's syndrome, insulin resistance syndrome, atherothrombogenic syndrome. J Cardiovasc Pharmacol 1992; 20(Suppl 8):S5-10.
2. Nygård O, Vollset E, Refsum H, Brattstrøm L, Ueland PM. Total homocysteine and cardiovascular disease. J Intern Med 1999;246:425-54.
3. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 2000;86(Suppl):3J-9J.
4. Drevon CA. Marine oils and their effects. Nutr Rev 1992;50:29-36.
5. Fischer S. Dietary polyunsaturated fatty acids and eicosanoid formation in humans. Adv Lipid Res 1989;23:169-98.
6. Kinsella JE, Lokesh B, Stone RA. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr 1990;52:1-28.
7. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease: clinical and mechanistic perspectives. Atherosclerosis 2008;197:12-24.
8. Bang HO, Dyerberg J. Lipid metabolism and ischemic heart disease in Greenland Eskimos. In: Draper HH, ed. Advanced Nutrition Research. Vol 3. New York: Plenum Press 1980:1-32.
9. Grundt H, Nilsen DWT, Mansoor A, Hetland Ø, Nordøy A. Reduction in homocysteine by n-3 polyunsaturated fatty acids after 1 year in a randomised double-blind study following an acute myocardial infarction: no effect on endothelial adhesion properties. Pathophysiol Haemost Thromb 2003;33:88-95.
10. Grundt H, Nilsen DW, Mansoor AM, Nordøy A. Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction. Eur J Clin Nutr 2003;57:793-800.
11. Guallar E, Sanz-Gallardo MI, van't Veer P, Bode P, Aro A, Gomez-Aracena J, et al. Mercury, fish oils, and the risk of myocardial infarction. Heavy Metals and Myocardial Infarction Study Group. N Engl J Med 2002;347:1747-54.
12. Nilsen DWT, Albrektsen G, Landmark K, Moen S, Aarsland T, Woie L. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr 2001;74:50-6.
13. Kromhout D, Bosschieter EB, Coulander CL. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9.
14. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997;336:1046-53.
15. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-8.
16. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 1989;2:757-61.
17. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet 1999;354:447-55.
18. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, et al. Risks and benefits of omega-3 fats for mortality, cardiovascular disease and cancer: systematic review. BMJ 2006;332:752-60.
19. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298-304.
20. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, et al. Prevention of fatal arrhythmias in high-risk subjects by fish-oil n-3 fatty acid intake. Circulation 2005;112:2762-8.
21. Schrepf R, Limmert T, Weber PC, Theisen K, Sellmayer A. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004;363:1441-2.
22. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897-903.
23. Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005;293:2884-91.
24. Brouwer IA, Zock PL, Camm AJ, Boecker D, Hauer RNW, Wever EFD, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA 2006;295:2613-9.
25. Jenkins DJA, Josse AR, Beyene J, Burr ML, LaBelle R, Kendall CWC, et al. Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. CMAJ 2008;178:157-64.
26. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health. Evaluating the risks and the benefits. JAMA 2006;296:1885-99.
27. Harris WS. Omega-3 fatty acids and cardiovascular disease: omega-3 index as a new risk factor. Pharmacol Res 2007;55:217-23.
28. London B, Albert C, Anderson ME, Giles WR, van Wagoner DR, Balk E, et al. Omega-3 fatty acids and cardiac arrhythmia: prior studies and recommendations for future research: a report from the National Heart, Lung and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis workshop. Circulation 2007;116;e320-e35.
29. Del Turco S, Basta G, Lazzerini G, Evangelista M, Rainaldi G, Tanganelli P, et al. Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction. Haematologica 2008;93:892-9.